The next generation tissue diagnostics device

18 of the finest startup companies from Switzerland were invited to the Investor Summit, where 200 investors and Top CEOs were present on their way to the World Economic Forum (WEF). This video has been made for this event: http://bit.ly/2ixhBkU

ABOUT LUNAPHORE
Lunaphore is a Swiss startup company, building the next generation tissue diagnostics device. With its cutting-edge technology, developed at the Swiss Federal Institute of Technology (EPFL), tumor samples can be analyzed up to 20 times faster than existing methods and with higher precision as demonstrated through clinical studies.

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.

Register for more services

Partners

Contributors